PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari  Date: 2020-07-30

PCI Pharma extends global clinical supply-chain services in Europe

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin.

According to credible sources, the new COE facility is PCI Pharma’s efforts to extend its clinical supply-chain network in Europe, which would complement the existing services it provides in Ireland and UK.

The Berlin-based COE will cover a space of 17,000 square feet which will primarily focus on packaging, storing and distribution of pharmaceutical and biopharmaceutical therapies in Europe, sources claimed.

The facility is reportedly ideal to provide services to clinical trials eco-system in the region. It presently has around 38,100 active trial centers across Europe, of which France ranks first with 7,370 active trials followed by Germany, with around 4,418 trial centers.

VP and GM of Global Clinical Operations & Supply at PCI Pharma Services, Brian Keesee reportedly said that this expansion will enable the company to cater to the needs of European as well as global clients through the COE facility in Berlin. He further claimed that Berlin is an exceptional logistics center and will ensure minimum disruptions in the supply-chain amid Brexit.

Salim Haffar, CEO at PCI Pharma Services, also stated that the company’s strategy has always focused on increasing the capacity as well as the capabilities of its network of clinical trial services. He added that the recent acquisition of Bellwyck Pharma Services will enable PCI Pharma to improve its capabilities through the Berlin facility, in a bid to support the flourishing clinical trial sector in Europe.

Salim also confirmed that the recent investment will facilitate the company to offer clinical trial solutions of their advanced medicines to clients across the globe.

For those uninitiated, PCI Pharma is a major contributor to global healthcare industry since it offers drug development solutions that help in enhancing numerous medical products.

Source credits: https://www.businesswire.com/news/home/20200728005211/en/PCI-Pharma-Services-Announces-Global-Expansion-Clinical

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
By Akshay Kedari

Chinese biotechnology company, CStone Pharmaceuticals has recently announced that it has completed the Share Subscription Agreement with Pfizer Inc. for its newly issued shares worth US$200 million. The move furthers the biotech’s multifaceted ...

Researchers bag $6Mn grant to study the link between Parkinson’s & aging
Researchers bag $6Mn grant to study the link between Parkinson’s & aging
By Akshay Kedari

A three-year grant worth $6 million, funded by the Michael J. Fox Foundation, was recently awarded to a collaborative research team from Michigan’s Van Andel Institute (VAI) and the University of Minnesota Medical School. The grant was given th...

EY announces availability of OpsChain Network Procurement solution
EY announces availability of OpsChain Network Procurement solution
By Akshay Kedari

Ernst & Young (EY), a global professional services network, has recently announced the availability of a first-of-its-kind OpsChain Network Procurement solution. The solution has been built on the company’s OpsChain platform. It will enabl...

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...